Antisense Oligonucleotides Specific for the HER2/neu Oncogene Inhibit the Growth of Human Breast Carcinoma Cells That Overexpress HER2/neu

This publication has 27 references indexed in Scilit:

• ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling
  The EMBO Journal, 1997
• A neu acquaintance for ErbB3 and ErbB4: A role for receptor heterodimerization in growth signaling
  Cell, 1994
• Mechanisms of p155^HER2 Expression in Human Non-Small Cell Lung Cancer Cell Lines
  American Journal of Respiratory Cell and Molecular Biology, 1992
• Expression of c-erbB-2 in Human Pancreatic Adenocarcinomas
  Pathobiology, 1991
• Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
  Science, 1989
• Inhibition of tumor growth by a monoclonal antibody reactive with an oncogene-encoded tumor antigen.
  Proceedings of the National Academy of Sciences, 1986
• Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu Oncogene
  Science, 1985
• The neu Gene: an erb B-Homologous Gene Distinct from and Unlinked to the Gene Encoding the EGF Receptor
  Science, 1985
• Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies
  Cell, 1985
• The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen
  Nature, 1984